Jason H. Karnes
- Health Informatics top 2%
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 13
- Drug-Induced Adverse Reactions 4
- Internal Medicine top 10%
- Transplantation top 10%
-
- Genetic Associations and Epidemiology 10
- Genomics and Rare Diseases 5
-
- Heparin-Induced Thrombocytopenia and Thrombosis 9
-
- Platelet Disorders and Treatments 8
-
- Hormonal Regulation and Hypertension 5
-
- Blood Pressure and Hypertension Studies 4
- Co-authors
- Heidi E. SteinerSaumya Shekhar JamuarAlan R. MoodyTim HulsenOrsolya VargaRoberto SpreaficoEoin McKinneyD Hafler
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Jason H. Karnes
60 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Health Informatics 51
- Pharmacology 251
- Health Information Management 61
- Internal Medicine 40
- Transplantation 27
Countries citing papers authored by Jason H. Karnes
This map shows the geographic impact of Jason H. Karnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason H. Karnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason H. Karnes more than expected).
Fields of papers citing papers by Jason H. Karnes
This network shows the impact of papers produced by Jason H. Karnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason H. Karnes. The network helps show where Jason H. Karnes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jason H. Karnes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 25 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 5 | |
| 11 | From Big Data to Precision Medicinebreakdown → | 2019 | 258 |
| 12 | 2018 | 10 | |
| 13 | 2017 | 74 | |
| 14 | 2017 | 44 | |
| 15 | 2016 | 8 | |
| 16 | 2015 | 27 | |
| 17 | 2014 | 42 | |
| 18 | 2014 | 30 | |
| 19 | 2009 | 25 | |
| 20 | 2007 | 21 |
About Jason H. Karnes
Jason H. Karnes is a scholar working on Pharmacology, Hematology and Internal Medicine, having authored 62 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (13 papers), Genetic Associations and Epidemiology (10 papers), Heparin-Induced Thrombocytopenia and Thrombosis (9 papers), Platelet Disorders and Treatments (8 papers), Genomics and Rare Diseases (5 papers), Hormonal Regulation and Hypertension (5 papers), Drug-Induced Adverse Reactions (4 papers) and Blood Pressure and Hypertension Studies (4 papers). The work is most often cited by research in Health Informatics (51 citations), Pharmacology (251 citations) and Health Information Management (61 citations). Jason H. Karnes has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Heidi E. Steiner, Saumya Shekhar Jamuar, Alan R. Moody, Tim Hulsen, Orsolya Varga, Roberto Spreafico, Eoin McKinney, D Hafler, Elizabeth J. Phillips and Dan M. Roden.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.